J. Fokam

J. Dorfman, W. Burgers, D. Martin, 2015, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Comparative Evaluation of Subtyping Tools for Surveillance of Newly Emerging HIV-1 Strains

Francesco Montella, Claudia Alteri, Vanni Borghi, 2017, Journal of Clinical Microbiology.

Molecular and Genetic Characterization of HIV-1 Tat Exon-1 Gene from Cameroon Shows Conserved Tat HLA-Binding Epitopes: Functional Implications

A. Njamnshi, C. Kouanfack, D. Mbanya, 2016, Viruses.

Pre-existing immunity to SARS-CoV-2 before the COVID-19 pandemic era in Cameroon: A comparative analysis according to HIV-status

C. Montesano, Y. Boum, V. Colizzi, 2023, Frontiers in Immunology.

Comparative Performance of Serological (IgM/IgG) and Molecular Testing (RT-PCR) of COVID-19 in Three Private Universities in Cameroon during the Pandemic

J. Fokam, M. Singwé-Ngandeu, T. Apalata, 2023, Viruses.

Predictors of Virologic Failure on First-line Antiretroviral Therapy Among Children in a Referral Pediatric Center in Cameroon

J. Fokam, A. N. Njom Nlend, S. Ndiang, 2017, The Pediatric infectious disease journal.

Immuno-virological response and associated factors amongst HIV-1 vertically infected adolescents in Yaoundé-Cameroon

S. Billong, J. Fokam, Koki Ndombo Paul, 2017, PloS one.

Outcomes of protease inhibitor-based antiretroviral therapy amongst children and associated-factors in Yaoundé, Cameroon

J. Fokam, P. K. Koki Ndombo, A. N. Nga Motaze, 2019, PloS one.

Next-generation sequencing provides an added value in determining drug resistance and viral tropism in Cameroonian HIV-1 vertically infected children

F. Ceccherini‐Silberstein, V. Colizzi, C. Fokunang, 2018, Medicine.

Dolutegravir-Based Regimen Ensures High Virological Success despite Prior Exposure to Efavirenz-Based First-LINE ART in Cameroon: An Evidence of a Successful Transition Model

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2022, Viruses.

Evaluation of Circulating and Archived HIV-1 Integrase Drug-Resistance Variants among Patients on Third-Line ART in Cameroon: Implications for Dolutegravir-Containing Regimens in Resource-Limited Settings

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2022, Microbiology spectrum.

Feasibility and utility of active case finding of HIV-infected children and adolescents by provider-initiated testing and counselling: evidence from the Laquintinie hospital in Douala, Cameroon

J. Fokam, C. Penda, C. E. Moukoko, 2018, BMC Pediatrics.

High performance of integrase genotyping on diverse HIV-1 clades circulating in Cameroon: toward a successful transition to dolutegravir-based regimens in low and middle-income countries.

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2021, Diagnostic microbiology and infectious disease.

Determinants of switch to paediatric second‐line antiretroviral therapy after first‐line failure in Cameroon

J. Fokam, Anne‐Esther Njom‐Nlend, Nadege Efouba, 2021, Tropical medicine & international health : TM & IH.

Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings.

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2021, The Journal of antimicrobial chemotherapy.

HIV-1 Drug Resistance and Genetic Diversity among Vertically Infected Cameroonian Children and Adolescents

V. Colizzi, F. Njiokou, C. Perno, 2020, Exploratory Research and Hypothesis in Medicine.

HIV-1 Drug Resistance and Genetic Diversity among Vertically Infected Cameroonian Children

J. Fokam, B. Dambaya, E. Ngoufack, 2019 .

HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing

T. F. Rinke de Wit, D. Katzenstein, R. Shafer, 2015, PloS one.

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine.

D. Katzenstein, N. Ford, R. Shafer, 2013, The Journal of infectious diseases.

Rate of virological failure and HIV-1 drug resistance among HIV-infected adolescents in routine follow-up on health facilities in Cameroon

C. E. Eboumbou Moukoko, J. Fokam, A. Ndjolo, 2022, PloS one.

Factors associated with risk of HIV-infection among pregnant women in Cameroon: Evidence from the 2016 national sentinel surveillance survey of HIV and syphilis

S. Billong, C. Nkenfou, J. Fokam, 2018, bioRxiv.

The mother-to-child transmission of HIV-1 and profile of viral reservoirs in pediatric population: A systematic review with meta-analysis of the Cameroonian studies

F. Ceccherini‐Silberstein, N. Kamgaing, C. Nkenfou, 2023, PloS one.

Programmatic Challenges in Implementing PMTCT Option B+ and Pediatric HIV Care: Baseline Assessment from “Save the Families for Africa” in Malawi

C. Perno, M. Santoro, J. Fokam, 2019 .

The problem of lost to follow-up of mother-child pairs enrolled in the PMTCT program in Dschang District Hospital-Cameroon.

Émeline Zogning Makemjio, V. Colizzi, G. Russo, 2018, Igiene e sanita pubblica.

Feasibility Study of HIV Sentinel Surveillance using PMTCT data in Cameroon: from Scientific Success to Programmatic Failure

O. Bolu, Georges Nguefack-Tsague, S. Billong, 2017, BMC Infectious Diseases.

Programme quality indicators of HIV drug resistance among adolescents in urban versus rural settings of the centre region of Cameroon

V. Colizzi, C. Fokunang, C. Perno, 2020, AIDS Research and Therapy.

HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon

F. Ceccherini‐Silberstein, V. Colizzi, C. Fokunang, 2019, BMC Infectious Diseases.

HIV-1 Drug Susceptibility to Potential Second- and Third-Line Antiretroviral Regimens among Cameroonian Patients: Evidence from a Cross-sectional Design.

F. Ceccherini‐Silberstein, V. Colizzi, J. Eberle, 2016, Current HIV research.

Population-Based Monitoring of Emerging HIV-1 Drug Resistance on Antiretroviral Therapy and Associated Factors in a Sentinel Site in Cameroon: Low Levels of Resistance but Poor Programmatic Performance

V. Colizzi, S. Billong, J. Fokam, 2013, PloS one.

HIV-1 transmission and survival according to feeding options in infants born to HIV-infected women in Yaoundé, Cameroon

J. Fokam, A. Sandie, A. N. Njom Nlend, 2018, BMC Pediatrics.

HIV-1 Early Infant Diagnosis is an Effective Indicator of the Prevention of Mother-to-Child Transmission Program Performance: Experience from Cameroon.

V. Colizzi, S. Billong, C. Nkenfou, 2015, Current HIV research.

Predictors of poor retention on antiretroviral therapy as a major HIV drug resistance early warning indicator in Cameroon: results from a nationwide systematic random sampling

V. Colizzi, S. Billong, A. Bisseck, 2016, BMC Infectious Diseases.

Evaluation of archived drug resistance mutations in HIV‐1 DNA among vertically infected adolescents under antiretroviral treatment in Cameroon: Findings during the COVID‐19 pandemic

F. Ceccherini‐Silberstein, Y. Boum, V. Colizzi, 2023, HIV medicine.

Research priorities for accelerating the achievement of three 95 HIV goals in Cameroon: a consensus statement from the Cameroon HIV Research Forum (CAM-HERO)

E. Sobngwi, J. Ditekemena, S. Billong, 2021, The Pan African medical journal.

Predictors of Non-Adherence to Antiretroviral Therapy among Adolescents Living with HIV in the Centre Region of Cameroon

F. Assah, M. Ngowe, J. Fokam, 2019 .

Water supply, sanitation and health risks in Douala 5 municipality, Cameroon.

V. Colizzi, G. Antonini, E. Temgoua, 2015, Igiene e sanita pubblica.

Detection of Gag C-terminal mutations among HIV-1 non-B subtypes in a subset of Cameroonian patients

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2022, Scientific Reports.

The Public Health perspective on Migratory Health – Displaced Populations in Global Disease Epidemics

C. Fokunang, E. Tembe-Fokunang, L. Kaptue, 2015 .

Evaluation of HIV-1 capsid genetic variability and lenacapavir (GS-6207) drug resistance-associated mutations according to viral clades among drug-naive individuals.

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2022, The Journal of antimicrobial chemotherapy.

Plant microRNAs from Moringa oleifera Regulate Immune Response and HIV Infection

C. Montesano, A. Desideri, F. Iacovelli, 2021, Frontiers in Pharmacology.

Highlighting a population-based re-emergence of Syphilis infection and assessing associated risk factors among pregnant women in Cameroon: Evidence from the 2009, 2012 and 2017 national sentinel surveillance surveys of HIV and syphilis

S. Billong, J. Fokam, C. Kengne-Ndé, 2020, PloS one.

Youth Awareness on Sexually Transmitted Infections, HIV and AIDS in Secondary Schools in the Dschang Municipality (Cameroon): The Mobile Caravan Project

V. Colizzi, M. Sobze, G. Russo, 2016, Journal of public health in Africa.

Knowledge, attitudes and practices on HIV / AIDS in the south region of Cameroon: case of the town of Kribi.

V. Colizzi, G. Russo, A. Panà, 2014, Igiene e sanita pubblica.

Decreased Inaccuracies in HIV Screening following Strengthening of Quality System: Evidence-based Interventions through the PMTCT Program in Cameroon

V. Colizzi, S. Billong, A. Bissek, 2019 .

An Overview of The Public Health Global Perspective on the Grand Challenges of Non-Communicable and Chronic Diseases Within the Framework for Developing new Drugs

C. Fokunang, E. Tembe-Fokunang, R. Langsi, 2015 .

Hepatitis B Virus and Behavioural Risk among Blood Donors, Gabon

J. Fokam, T. Nkoa, D. Maulot-Bangola, 2022, International Blood Research & Reviews.

Prevalence and risk factors of Hepatitis B virus infection among blood donors in Gabonese National Blood Transfusion Center: A cross-sectional and analytic study

J. Fokam, T. Nkoa, D. Maulot-Bangola, 2021 .

Infection of Pregnant Women with Human Immunodeficiency Virus, Hepatitis B Virus and Associated Risk Factors in Semi-rural Health District, Cameroon

J. Fokam, R. Moyou, CT Ngounouh, 2020 .

The 2nd International Conference on Public Health in Africa

V. Colizzi, N. Ndembi, A. Muwonge, 2023, Journal of Public Health in Africa.

Evaluation of the nutritional status of infants from mothers tested positive to HIV/AIDS in the health district of Dschang, Cameroon

V. Colizzi, R. G. Wadoum, M. Sobze, 2014, The Pan African medical journal.

Diagnostic performance of a colorimetric RT -LAMP for the identification of SARS-CoV-2: A multicenter prospective clinical evaluation in sub-Saharan Africa

E. Buratti, L. De Conti, C. Stuani, 2021, EClinicalMedicine.

Virological response, HIV-1 drug resistance mutations and genetic diversity among patients on first-line antiretroviral therapy in N’Djamena, Chad: findings from a cross-sectional study

M. Moutschen, A. Moussa, C. Adawaye, 2017, BMC Research Notes.

HIV-1 Drug Susceptibility to Potential Second- and Third-Line Antiretroviral Regimens among Cameroonian Patients: Evidence from a Crosssectional Design

F. Ceccherini‐Silberstein, V. Colizzi, J. Eberle, 2017 .

The declining trend of HIV-Infection among pregnant women in Cameroon infers an epidemic decline in the general population

S. Billong, J. Fokam, A. Ndjolo, 2020, Heliyon.

An apparent paradox: resistance mutations in HIV-1 DNA predict improved virological responses to antiretroviral therapy.

L. Bonnett, A. Geretti, C. Kouanfack, 2019, The Journal of antimicrobial chemotherapy.

Challenges faced by the HIV testing system in low- and middle-income countries

A. Nanfack, J. Fokam, A. Ndjolo, 2023, African Journal of Laboratory Medicine.

High viremia and Poor Immunity are Potential Surrogates of Anti-toxoplasmic Immunoglobulin G Quantification among HIV-Infected Individuals: A Cross-sectional Study in Yaoundé, Cameroon

V. Colizzi, J. Fokam, A. Ndjolo, 2020 .

Evaluation of plasma viral-load monitoring and the prevention of mother-to-child transmission of HIV-1 in three health facilities of the Littoral region of Cameroon

A. Saniotis, J. Fokam, T. Nana, 2022, PloS one.

Prevalence of HIV, HBV and chlamydia infections in Cameroonian University context: case of the University of Dschang, in the Western region

P. M. N. Pete, V. Colizzi, M. Sobze, 2014, BMC Infectious Diseases.

Genetic Diversity of HIV-1 and Transfusion Safety : Systematic Review and Concepts Analysis

J. Fokam, T. Nkoa, Christian Mangala, 2021, International STD Research & Reviews.

Viral suppression in the era of transition to dolutegravir-based therapy in Cameroon: Children at high risk of virological failure due to the lowly transition in pediatrics

V. Colizzi, C. Perno, S. Billong, 2023, Medicine.

KIR2DL1 gene is a surrogate marker of protection against infection-related hospitalisation among HIV-1 unexposed versus exposed uninfected infants in Cameroon

J. Fokam, Luc-Aimé Kagoué Siméni, J. C. Assob Nguedia, 2023, medRxiv.

Prevalence and risk factors to HIV-infection amongst health care workers within public and private health facilities in Cameroon

S. Billong, N. Kamgaing, J. Fokam, 2018, The Pan African medical journal.

Pre-Treatment HIV Drug Resistance and Genetic Diversity in Cameroon: Implications for First-Line Regimens

F. Ceccherini‐Silberstein, V. Colizzi, C. Fokunang, 2023, Viruses.

Thrombocytopenia according to antiretroviral drug combinations, viremia and CD4 lymphocytes among HIV-infected patients in Cameroon: a snapshot from the City of Yaoundé

V. Colizzi, A. Nanfack, J. Fokam, 2019, BMC Research Notes.

CLINICAL PHARMACOKINETICS CONCEPTS IN THE DRUG DISCOVERY AND DEVELOPMENT PROCESS OF PHYTOMEDICINES IN SOME DEVELOPING COUNTRIES

M. Gorny, A. Nanfack, J. Fokam, 2018 .

Current practice of epidemiology in Africa: highlights of the 3rd conference of the African epidemiological association and 1st conference of the Cameroon society of epidemiology, Yaoundé, Cameroon, 2014

C. Victora, K. Akinroye, V. Colizzi, 2015, The Pan African medical journal.

Determinants of Retention on the Prevention of Mother-to-Child HIV Transmission (Option B+) in Cameroon

S. Billong, J. Fokam, C. Penda, 2019 .

Human papillomavirus positivity and cervical lesions in relation to HIV infection: a comparative assessment in the Cameroonian female population

V. Colizzi, S. Billong, Z. Sando, 2023, Journal of Public Health in Africa.

Genetic diversity of the human immunodeficiency virus of type 1 in Gabonese transfusional settings

J. Fokam, T. Nkoa, D. Maulot-Bangola, 2023, BMC Infectious Diseases.

Mapping and size estimates of female sex workers in Cameroon: Toward informed policy for design and implementation in the national HIV program

J. Blanchard, S. Isac, Georges Nguefack-Tsague, 2019, PloS one.

Drug Resistance Among Drug-naive and First-line Antiretroviral Treatment-failing Children in Cameroon

V. Colizzi, P. Ndumbe, C. Perno, 2011, The Pediatric Infectious Disease Journal.

COVID-19 preventive social-behavioural practices and exposure to SARS-CoV-2 among residents in the city of Yaounde: Lessons from the early phase of the pandemic in Cameroon

V. Colizzi, K. C. Nwosu, O. Keiser, 2023, PLOS global public health.

Variability of High-Risk Human Papillomavirus and Associated Factors among Women in Sub-Saharan Africa: A Systematic Review and Meta-Analysis

V. Colizzi, C. Perno, J. Fokam, 2023, Pathogens.

Inflammatory profile of vertically HIV-1 infected adolescents receiving ART in Cameroon: a contribution toward optimal pediatric HIV control strategies

F. Ceccherini‐Silberstein, C. Montesano, V. Colizzi, 2023, Frontiers in immunology.

Evaluation of HIV-1 DNA levels among adolescents living with perinatally acquired HIV-1 in Yaounde, Cameroon: A contribution to paediatric HIV cure research in Sub-Saharan Africa

F. Ceccherini‐Silberstein, V. Colizzi, M. Santoro, 2024, Journal of virus eradication.

Characterisation of HIV-1 reservoirs in paediatric populations: protocol for a systematic review and meta-analysis

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2023, BMJ Open.

Laboratory Based Surveillance of HIV-1 Acquired Drug Resistance in Cameroon: Implications for Use of Tenofovir-Lamivudine-Dolutegravir (TLD) as Second- or Third-Line Regimens

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2023, Viruses.

HIV-1 subtype diversity and immuno-virological outcomes among adolescents failing antiretroviral therapy in Cameroon: A cohort study

V. Colizzi, C. Perno, M. Santoro, 2023, PloS one.

Performance characteristics of INDICAID antigen rapid diagnostic test on SARS-CoV-2 samples during the omicron wave in Cameroon

V. Colizzi, J. Fokam, A. Ndjolo, 2024, Heliyon.

Current knowledge of human Mpox viral infection among healthcare workers in Cameroon calls for capacity-strengthening for pandemic preparedness

V. Colizzi, J. Fokam, A. Ndjolo, 2024, Frontiers in public health.

Gag P2/NC and pol genetic diversity, polymorphism, and drug resistance mutations in HIV-1 CRF02_AG- and non-CRF02_AG-infected patients in Yaoundé, Cameroon

A. Njamnshi, D. Mbanya, J. Fokam, 2017, Scientific Reports.

Performance characteristcis of Allele-Specific PCR (ASPCR) in detecting drug resistance mutations among non-B HIV-1 Variants

C. Adawaye, J. Fokam, A. Tidjani, 2023, Journal of Virological Methods.

Performance of rapid subtyping tools used for the classification of HIV type 1 recombinants isolated from selected countries in west and central Africa

J. Torimiro, W. Mbacham, J. Fokam, 2016 .

Early Warning Indicators for HIV Drug Resistance in Cameroon during the Year 2010

V. Colizzi, P. Ndumbe, S. Billong, 2012, PloS one.

HIV drug resistance to integrase inhibitors in low- and middle-income countries.

V. Colizzi, J. Fokam, Nicaise Ndembi, 2024, Nature medicine.